ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Machine Learning Improves Kidney Discard Predictability

    M. Barah1, S. Mehrotra2

  • Machine Learning Model Outperforms Linear Regression Models for 1- and 3-Year Post-Transplant Survival: Is This the Future?

    R. W. Pettit1, S. J. Corr2, J. Havelka3, A. Rana1

  • Machine Learning to Predict Deceased Donor Kidney Biopsy Results

    C. Martinez, A. Placona

  • Machine Learning to Predict Deceased Donor Liver Biopsy Results

    C. Martinez, A. Placona

  • Maintenance Belatacept Therapy is Associated with Increased Rates of Polyoma Viremia

    D. Conti, E. Maciera, D. Pluckrose, M. Garner, D. Schuster, S. Patel

  • Maintenance Steroids in the Setting of Alemtuzumab Induction Post-Kidney Transplant Increases Risk of Infection and Hospital Readmission

    A. R. Webb, A. A. Al-Bahou, A. J. Brueckner, A. T. Logan, R. S. Baliga, L. J. Bowman Anger

  • Major Adverse Cardiovascular Events (MACE) in Living Kidney Donors (LKDs)

    M. Merzkani1, A. Denic1, M. D'Costa1, L. Ricaurte1, R. Narasimhan1, X. Benavides1, A. Mullan1, J. Larson1, W. Park1, M. P. Alexander1, H. Chakkera2, S. Textor1, S. Taler1, M. Stegall1, N. Issa1, A. Rule1

  • Making History, Saving Lives: One OPOs Experience Making History by Being the First in the Nation to Successfully Allocate Seven Organs for Transplant from a Donation after Circulatory Death (DCD) Donor

    J. B. Nave, A. J. Boyer, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski

  • Male Native Hawaiians and Pacific Islanders are at Risk for Delayed Graft Function after Renal Transplantation

    L. Lee1, K. Bozhilov2, L. L. Wong2

  • Malignancy Incidence after Pediatric Kidney Transplantation; a Single-Center Experience in Japan

    Y. Aoki1, H. Satoh1, R. Hamada2, R. Harada2, M. Muramatsu3, Y. Hamasaki3, S. Shishido3

  • Management and Outcomes of Heart Transplant Recipients with Pre-Transplant Left Ventricular Assist Device Infections

    Z. Esquer Garrigos, P. Vijayvargiya, J. M. Stulak, S. A. Rizza, M. R. Sohail

  • Management of Adenovirus Enteritis after Intestinal Transplantation

    E. Sherman1, N. Beltran2, Y. Muszkat3, S. Jafri3

  • Management of Hepatic Artery Stenosis Post Liver Transplant

    S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta

  • Management of Pancreatic Cancer after Liver Transplantation: A 27-Year Single-Center Experience

    I. A. Ziogas, M. A. Rauf, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. P. Alexopoulos

  • Managing the Road to Kidney Transplantation in the Elderly

    R. S. Munjal, K. Kalra, A. Cherukuri, D. Jorgensen, S. Verma, P. Sood, R. Mehta, C. Puttarajappa, S. Hariharan, C. Wu

  • Marginal Livers Have Excellent Outcomes in Pediatric Patients with Metabolic Liver Disease

    M. MacConmara, C. Feizpour, D. Desai, S. Hanish, P. Vagefi, A. Aqul, C. S. Hwang

  • Marginal Not So Marginal Anymore: Time for New Definitions for “Marginal” Allografts in Liver Transplantation?

    T. Zhang1, J. Dunson1, F. Kanwal2, T. Galvan2, J. Vierling2, C. O'Mahony2, J. Goss2, A. Rana2

  • Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts

    V. Gorbacheva, R. Fan, W. Baldwin, R. Fairchild, A. Valujskikh

  • Marijuana Use Among Liver Transplant Recipients

    K. G. Yan, L. Forman

  • Mass Cytometry-Based Immunoprofiling as a Tool to Predict Rejection in a Large Cohort of Pediatric Transplant Recipients

    M. Rao1, J. T. Harden2, M. Lapasaran2, C. O. Esquivel3, O. M. Martinez2, S. M. Krams2

  • Mass-Spectrometry Based Discovery of Tubular Injury Marker in Chronic Kidney Disease

    J. Kim1, D. Han1, J. Jeong2, J. Moon1, S. Lee3, Y. Kim1, K. Yoo4, D. Kim1, Y. Kim1, S. Yang1

  • Maternal Peripartum Complications in Solid Organ Transplantation

    R. X. Wang1, G. S. Lee-Riddle2, D. O. Walls3, D. S. Goldberg4, P. L. Abt2

  • Maximizing the Gift: One OPO’s Experience Maximizing the Gift of Organ Donation by Successfully Increasing the Number of Organs Transplanted from Non-Braindead Donors

    J. B. Nave, A. J. Boyer, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski

  • Maximizing Utilization of Marginal Kidneys in a Small, Geographically Isolated Transplant Program: 10 Year Experience

    J. Africa, R. King, L. Lipscomb, A. Patel, A. Jones

  • Measuring and Monitoring Equity in Access to Deceased Donor Lung Transplants among Lung Registrations

    R. R. Goff1, E. D. Lease2, S. Sweet3, A. Robinson1, D. Stewart1

  • Measuring Environmental Elemental Exposure in the Hair Allows to Identify Kidney Transplant Recipients at Risk of Acute Rejection

    A. Angeletti1, I. Gandolfini2, C. Cantarelli2, U. Maggiore2, L. Gaetano1, E. Fiaccadori2, J. Reid-Adam3, J. Saland3, P. Curtin3, A. Curtin3, C. Austin3, P. Cravedi3

  • Mechanisms by Which Donor Bone-Marrow CXCR4+ Foxp3+ Tregs Promote Long-Term Survival of Murine Limb Allografts

    L. Wang1, Z. Wang2, R. Han1, A. Samanta1, G. Ge1, L. S. Levin1, M. H. Levine1, W. W. Hancock3

  • Medical and Psychosocial Reasons for Deferral and Denial Following Kidney Transplant Evaluation at a VA Transplant Center

    D. Katz1, E. Siniff2, M. L. Sanders3, P. Manay1, P. Ten Eyck4

  • Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant

    J. Trofe-Clark1, G. Malat1, M. Norris1, D. Sawinski2, M. Bleicher2, R. Bloom2

  • Medication Adherence in Thoracic Transplant Candidates

    K. Pennington1, R. Benzo1, S. Jowsey1, M. Budev2, S. Chandreashekaran3, D. Erasmus4, E. Lease5, D. Levine6, K. Thompson1, D. Yip4, B. Hardaway7, S. Dunlay1, C. Kennedy1

  • Medication Knowledge Improves in Adolescent Kidney Transplant Patients with in Clinic Pharmacy Education

    C. G. Peterson1, E. Benefield2, C. Heyrend2

  • Medication Knowledge Retention and Adherence Following Transplant: Is There Room for Improvement?

    M. H. Cooper1, A. W. Rogers1, T. L. Menser2, J. C. Krisl1

  • Medication Non-Adherence (MNA) Mitigation Practices and Health Care Professional (HCP) Perceptions at U.S. Transplant Centers

    S. J. Patel1, J. L. Descourouez2, B. Hofmeyer3, C. A. Moore4, D. Nguyen5, E. Graviss5, D. J. Taber6

  • Megacystis Microcolon Intestinal Hypoperistalsis Syndrome: A Case Series with Long Term Follow Up and Prolonged Survival

    K. M. Prathapan1, V. Raghu1, A. Ganoza2, K. Ackerman1, T. Presel1, J. A. Yaworski1, W. Sevilla1, D. King1, J. Rudolph1, F. Alissa1

  • MELD is MELD is MELD? Geographic/ Center-Level Variation in Mortality for Patients with the Same MELD Score

    T. Ishaque1, A. B. Massie1, A. B. Kernodle1, S. Getsin1, P. Chaing1, J. G. Jacqueline Garonzik Wang1, S. Gentry2, D. Segev1

  • Membrane Expression of CD163 and CD206 by Blood Monocytes is Upregulated in Kidney Allograft Recipients

    I. Striz, L. Curnova, V. Svachova, M. Fialova, M. Novotny, O. Viklicky

  • Memory T Cell-Mediated Rejection is Regulated by FcγRIIB Expression on CD8+ T Cells

    A. B. Morris, D. F. Pinelli, D. Liu, M. L. Ford

  • Mental Health of Unspecified Anonymous Living Kidney Donors after Donation

    W. Zuidema1, S. Ismail2, J. Wetering van de1, L. Raalten van2, W. Weimar1, E. Massey1

  • Mesenchymal Stromal Cell Treatment of Kidneys During Normothermic Machine Perfusion is Safe and Feasible with Effective Traceability after Transplantation

    K. Rozenberg1, S. Lohmann2, M. Pool3, M. Eijken4, U. Møldrup5, B. Møller6, J. Sierra-Parraga7, M. Hoogduijn7, L. Lo Faro1, C. Moers3, J. Hunter1, A. Keller2, H. Leuvenink3, C. Baan7, R. Ploeg1, B. Jespersen2

  • Metabolic Syndrome Predicts Worse Long-Term Renal Outcomes in Living Kidney Donors (LKDs)

    M. Merzkani1, A. Denic1, M. D'Costa1, L. Ricaurte1, R. Narasimhan1, X. Benavides1, A. Mullan1, J. Larson1, W. Kremers1, W. Park1, M. P. Alexander1, S. Textor1, S. Taler1, H. Chakkera2, M. Stegall1, N. Issa1, A. Rule1

  • Metabolism Reprogramming During Conventional versus Ischemia-Free Liver Transplantation

    Z. Guo1, Z. Zhang1, N. Gao1, H. Zhang2, X. He1

  • Metformin Improves Biomarkers of Calcineurin Inhibitor Related Nephrotoxicity

    M. R. Fernando, K. Taylor, S. Herath, A. Au, J. Erlich, Z. Endre

  • Methenamine for Prevention of Recurrent Urinary Tract Infections in Adult Solid Organ Transplant Recipients

    H. Sweiss1, S. Bhayana2, R. Hall1, J. Nelson1, E. Kincaide1

  • MHC II-Decoy Car-T Cells to Induce Long-Term Allotransplant Organ Tolerance

    W. McCall1, T. Baybutt1, A. Snook1, A. Shah2

  • Microarray and RNA-Seq Analysis of Rejection in Formalin-Fixed Paraffin-Embedded (FFPE) Biopsies: Comparing FFPE to Conventionally Stabilized (RNAlater Solution) Biopsies

    P. Halloran1, K. Famulski1, J. Reeve1, J. Huang2, N. Alexandrov2

  • Microbiota Modulates Ischemia-Reperfusion Injury in Mouse Liver Transplantation

    S. Kageyama1, H. Kojima1, K. Kadono1, H. Hirao1, K. J. Dery1, K. Nakamura2, T. Dong3, J. Jacobs3, R. W. Busuttil1, J. W. Kupiec-Weglinski1

  • microPOTS: A New Single Cell Proteomic Method for Profiling Human Kidney Transplant Biopsy Tissue

    T. Sigdel1, P. Piehowski2, S. Roy1, J. Liberto1, A. Schroeder1, P. Rashmi1, S. Sur1, I. Damm1, W. Qian2, M. M. Sarwal1

  • microRNA-223 in MSCS-Derived Exosomes Protects Against Renal Ischemia/Reperfusion Injury Through Inhibiting Pyroptosis Pathway via Directly Targeting NLRP3

    C. Ding, W. Xue

  • Microvascular Inflammation without DSA or C4d: An Orphan Category in Banff Classification with Intense Capillaritis and Cytotoxic T-Cell Infiltration

    A. Buxeda1, L. Llinàs-Mallol2, J. Gimeno3, C. Arias-Cabrales1, C. Burballa1, D. Redondo-Pachón1, D. Raïch-Regué2, M. Pérez-Sáez1, J. Pascual1, M. Crespo1

  • Mid-Term Outcomes after Treatment for Antibody-Mediated Rejection by De Novo Donor-Specific HLA Antibody in Renal Transplant Recipients: Does Early Treatment Lead to Better Outcomes?

    M. Okada1, T. Tomosugi1, T. Hiramitsu1, S. Narumi1, Y. Watarai1, A. Kanda1, K. Futamura1, N. Goto1, A. Takeda2

  • Migration of Passenger Leukocytes During Ex Vivo Warm Perfusion

    L. Brasile1, B. Stubenitsky2

  • Mindfulness at Methodist – Stress Resiliency Strategies for Patients

    E. Vivian1, H. Oduor2, P. Mantry3

  • Minor Negative Effects of Calcineurin Inhibitor Based Immunosuppression on Pregnancy Outcomes after Renal Transplantation in the Netherlands

    L. M. Koenjer1, J. R. Meinderts2, A. T. Lely3, M. F. de Jong2, O. W. van der Heijden1, R. G. van der Molen4, H. W. van Hamersvelt5

  • Mir-124/ire-1α Affects Renal Ischemia/Reperfusion Injury by Regulating Endoplasmic Reticulum Stress in Renal Tubularepithelial Cells

    C. Ding, W. Xue

  • Missing Self Increases the Incidence of Microvascular Inflammation after Kidney Transplantation

    J. Callemeyn1, A. Senev2, M. Coemans1, E. Lerut3, B. Sprangers1, D. Kuypers1, A. Koenig4, O. Thaunat4, M. Emonds2, M. Naesens1

  • Mitochondrial Metabolism is Enriched Following Normothermic Ex-Vivo Kidney Perfusion of Grafts Procured Following Cardiac Death

    P. Urbanellis1, C. McEvoy1, L. Mazilescu1, S. Ganesh1, R. John1, I. Mucsi1, A. Ghanekar1, D. Bagli2, A. Konvalinka1, L. Robinson2, M. Selzner1

  • Mitochondrion-Endothelial Interaction Generates Danger Signal in Promoting Costimulation-Resistant T Cell-Mediated Allograft Rejection

    S. Li1, M. Song1, Q. Li2, A. Kirk1, H. Xu1

  • Mobile Application for Communication Increases the Efficiency of Organ Procurement and Transplantation

    E. Pahl

  • Modelling Patient Outcomes after Listing for Deceased Donor Kidney Transplantation in the UK: A Novel Technique

    M. Ibrahim1, L. Mumford1, R. Hogg1, R. Johnson1, M. Pearson2, J. Forsythe3, C. Callaghan4

  • Modulating ITK Signaling Facilitate Allogeneic Skin Engraftment and Clear LCMV Viruses by Regulating IRF-4, JAK STAT and Eomes Expression

    M. Mammadli1, M. Karimi1, S. Mahmudlu1, A. August2, W. Huang2

  • Modulation of Ischemia Reperfusion Injury in Renal Transplantation Using Selective Estrogen Receptor Modulators

    P. T. Hernandez1, C. S. O'Brien1, S. J. Concors1, L. N. Krumeich1, W. Hancock2, M. H. Levine1

  • Molecular Diagnosis and Risk Prediction in BK Virus Nephropathy: Discovery and Multicenter Validation of Novel Intragraft Gene Expression Signatures

    B. Adam1, Z. Kikic2, Y. Bouatou3, J. Gueguen3, B. Robin3, G. Reid1, H. Regele2, M. Rabant3, A. Loupy3, M. Mengel1

  • Molecular Diagnosis of Rejection in Liver Transplant Biopsies: The INTERLIVER Study

    K. S. Madill-Thomsen1, P. F. Halloran2, .. The INTERLIVER Study Group3

  • Molecular Features of HLA Mismatches as Predictors of De Novo DSA Development: A Single Center Experience

    V. Jucaud1, L. Rebellato2, K. Briley2, C. Haisch2, S. Kendrick3, H. Jones3, K. Mclawhorn3, D. Leeser2, M. Everly1

  • Molecular Phenotypes of Liver Transplant Injury: The INTERLIVER Study

    K. S. Madill-Thomsen1, P. F. Halloran1, &. the INTERLIVER Study Group2

  • Molecular Profiles of Injury in Heart Transplant Allograft: Relationship to Rejection, Ejection Fraction, and Survival

    P. Halloran1, J. Reeve2, &. the INTERHEART Study Group3

  • Monitoring Inflammatory Cytokines in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts) Desensitized with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Followed by Transplantation (Tx)

    S. Ge1, A. Petrosyan1, M. Chu1, N. Ammerman2, A. Vo2, X. Zhang3, S. C. Jordan2, M. Toyoda1

  • Monitoring Recipients of Public Health Service (PHS) Increased Risk Donors Using an Electronic Medical Record-Based System

    M. Malinis1, B. Nuesse2, S. Carter2, S. Emre1, R. Formica1, S. Kulkarni1, D. Mulligan1, M. Schilsky1, M. M. Azar1

  • Monitoring the Removal of Donation Service Area from Lung Allocation

    R. R. Goff1, R. Daly2, E. D. Lease3

  • Morbid Obesity: A Growing Barrier to Early Kidney Transplant Wait-Listing in the United States

    L. Lavenburg1, E. Weinhandl2, L. Robinson3, B. Milliron4, C. Earthman5, A. Klassen3, M. Harhay6

  • Morbidity in Lung Transplant for Connective Tissue Disease

    S. Minkove1, E. Bush2, P. Shah1

  • Mortality Index Should Be Used to Provide Realistic Expectations Regarding Transplant Candidacy

    Y. Chalicheemala1, K. Chavin2, T. Srinivas1, A. Padiyar1

  • Most Complications of Hand-Assisted Laparoscopic Living Donor Nephrectomy Occur after Initial Discharge Including Most Reoperations: A Single-Center Retrospective Study

    X. Benavides, R. T. Rogers, E. Tan, M. A. Merzkani, S. Thirunavukkarasu, B. Smith, A. D. Rule, M. Prieto, J. K. Heimbach, T. Taner, G. K. Chow, P. G. Dean, M. D. Stegall

  • MTOR Inhibitor Management and Wound Complications in Liver Transplant Recipients Undergoing Subsequent Surgeries

    K. Neuhaus, B. Eghtesad, K. Hashimoto, M. Spinner, J. Bollinger, J. Eckardt

  • MTOR-Inhibitor Regimens and Malignancy after Kidney Transplantation: Can the Risk Be Modified by Considering Human Leukocyte Antigen (HLA) Mismatch in Immunosuppression Selection?

    A. Santos1, C. Chen1, K. Alquadan2, M. A. Leghrouz2, X. Wen3

  • Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability & Acceptance of the Marginal Living- Kidney Donors with Obesity or Abnormal Blood Sugar Profile

    Z. Arabi1, M. A. Bukhari2

  • Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Urological Issues

    Z. Arabi1, M. A. Bukhari2, S. Kaysi3, A. R. Altheaby1, E. A. Elhassan1, A. A. Mateen1, M. I. Abdalla1, M. Gafar1, S. A. Alam1, N. Abdulmajeed4, A. Alkurdi5, A. Hamad6

  • Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Active Heavy Smoking or Intermittent Drug Abuse

    Z. Arabi1, A. Hamad2, S. Kaysi3, M. Bukhari4

  • Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Mild Hypertension

    Z. Arabi1, E. Elhassan1, A. Altheaby1, A. Hamad2, S. Kaysi3

  • Multi- National Survey among Nephrologists & Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors with Sickle Cell Trait

    Z. Arabi1, A. Mateen1, A. Altheaby1, M. Bukhari2, A. Hamad3, S. Kaysi4, E. Elhassan1

  • Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Living Kidney Donors with Microscopic Hematuria

    Z. Arabi1, S. Kaysi2, A. Hamad3, M. Bukhari4

  • Multi- National Survey among Nephrologists and Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Family History of Kidney Disease

    Z. Arabi1, S. Kaysi2, A. Altheaby1, E. Elhassan1, M. Bukhari3, A. Mateen1, A. Hamad4

  • Multi-Center, Open-Label Trial of Pre-Emptive Glecaprevir/Pibrentasvir (G/P) to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus (MYTHIC)

    M. Sise1, D. Goldberg2, J. Kort3, D. Schaubel4, R. Alloway5, C. Durand6, R. Fontana7, J. Friedewald8, R. Brown9, S. Prenner10, R. Landis4, P. Reese11, R. Chung1

  • Multi-National Survey among Nephrologists and Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Age Discrepancy

    Z. Arabi1, S. Kaysi2, A. Hamad3, M. Bukhari4, A. Mateen1, E. Elhassan1, A. Altheaby1

  • Multi-Organ Procurement Organization Review of the Impact of Reactive Anti-HCV and HCV NAT Results

    C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski

  • Multicenter Evaluation of Cytomegalovirus Infection Following Intestinal and Multivisceral Transplantation

    M. Segovia1, Y. Patel1, S. Nagai2, D. Sudan1, S. Jafri2

  • Multidimensional System to Dynamically Predict Graft Survival after Kidney Transplantation

    M. Raynaud1, O. Aubert1, S. Jordan2, M. Stegall3, J. Friedewald4, D. Glotz1, C. Legendre1, D. Segev5, C. Lefaucheur1, A. Loupy, On behalf of the study NCT034740031

  • Multifaceted Roles of Follicular T Cell Subsets in Controlling Antibody Mediated Rejection

    M. T. Mohammed

  • Multifactorial Effect of Hepatocyte Growth Factor (HGF) on the Microscopic Regeneration of Liver Allograft in Recipients Who Underwent Transplantation from Living Donors

    B. H. Ozdemir1, G. Ozgun1, A. Yucel Polat1, M. Haberal2

  • Multimodal Strategy for Hepatocellular Carcinoma in the Elderly: To Transplant or Not to Transplant

    M. Najjar1, O. Perez1, J. Zou1, S. Sun1, K. Bruestle1, P. Jiang1, E. Verna1, E. Zheng1, Y. Saenger1, A. Mathur1, A. Griesemer1, B. Samstein2, T. Kato1, K. Halazun2, J. Emond1

  • Multimodal Theranostic Nanocolloid Platform for Imaging, Targeted Drug Delivery and Organ Preservation in Transplantation

    J. M. Janjic1, E. Lambert1, L. Liu1, M. Herneisey1, V. S. Gorantla2

  • Multiple Downstaging Episodes for Hepatocellular Carcinoma Prior to Liver Transplant Increases Risk of Post-Transplant HCC Recurrence

    K. Mishra, M. Siddiqui, A. Farris, R. Salgia

  • Multiplexed Imaging Mass Cytometry Analysis Reveals a New Role for CD68+ Macrophages in Chronic Liver Transplant Rejection

    J. Emamaullee, C. Man, J. Hoeflich, N. Ung, R. Sun, N. Matasci, J. Katz, J. Lee, S. Chopra, L. Sher, S. Asgharzadeh, O. Akbari, Y. Genyk

  • Multiplicity of Non-HLA Targets for Antibodies Developed in Association with Ventricular Assist Device Implantation

    M. Askar, D. Bhakta, H. Zafar, A. Alam, L. Pittmon, S. Kang, L. Klingman, J. Felius, S. M. Joseph, D. Wencker, D. M. Meyer, S. A. Hall

  • Muscle Strength and Physical Functioning in Pediatric Kidney Transplant Recipients

    K. Sgambat, K. Amatya, A. Moudgil

  • Muscle-Liver Crosstalk via the Myokine MG53 Plays a Critical Role in Hepatocellular Repair

    C. Akateh, J. Ko, B. F. Reader, J. Kim, Y. Lee, B. A. Whitson, J. Ma, S. M. Black

  • MY-ATLAS: A Novel Simulation Algorithm for Liver Transplant Allocation

    C. G. Rickert1, H. Zhao2, Z. Leung2, M. Akan3, J. F. Markmann1, S. Tayur3, H. Yeh1

  • Mycobacterium Abscessus Infection in Solid Organ Transplant Recipients Over Five Years. A Single Center Experience

    Y. Ebisu1, Y. Natori2, G. Rosello3, J. Simkins2, J. Camargo2, S. Anjan2, M. Morris2, O. V. Martinez4, L. Abbo2

  • Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

    S. J. Yusuf1, H. Bheemreddy1, A. Imtiaz2, N. Krishnan3

  • Mycophenolic Acid Exposure in Young, Middle Age and Older Stable Renal Transplant Recipients

    K. Tornatore1, K. Attwood2, R. Venuto3

  • Myeloid Derived Suppressor Cells Expanded by Granulocyte-Colony Stimulating Factor Prolong Allogeneic Cardiac Graft Survival When Compared with MDSCs Expanded by Different Means

    Y. S. Lee, T. Zhang, J. S. Bromberg, J. R. Scalea

  • Myosteatosis and its Impact on Graft- and Patient Survival in Adult Recipients of Deceased Donor Liver Transplantation

    Z. Czigany, W. Kramp, G. van der Kroft, P. Strnad, M. Zimmermann, W. Liu, G. Wiltberger, U. Neumann, G. Lurje

Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences